Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis
Background The relationship between venous thromboembolism (VTE) and immune checkpoint inhibitor therapy (ICI) is unclear. This analysis investigates the incidence of and risk factors for VTE in VTE-naive patients with cancer receiving ICI treatment.Methods A retrospective cohort study of patients r...
Saved in:
| Main Authors: | Jean M Connors, F Stephen Hodi, Michael Manos, Anita Giobbie-Hurder, Tamara A Sussman, Nicole R LeBoeuf, Ian D Dryg, Jason L Weirather |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e010761.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors
by: Michael S. Chang, MD, et al.
Published: (2025-02-01) -
Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis
by: Melissa Lumish, et al.
Published: (2020-05-01) -
Concurrent Arterial and Venous Thromboembolism While Receiving an Aromatase Inhibitor
by: Ibrahim Shahid, et al.
Published: (2024-08-01) -
Thromboembolism in patients with melanoma receiving immune checkpoint inhibitors: incidence and risk factors
by: D.C.H. van Dorst, et al.
Published: (2025-09-01) -
Venous thromboembolic complications
by: G. G. Khubulava, et al.
Published: (2019-02-01)